Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Simon

Showing results (711-720 of 732) with videos related to

Pageof 74
Sort By:
Neurology|January 20, 2010
Novel THAP1 sequence variants in primary dystoniaJ Xiao, Y Zhao, R W Bastian, et al.
Pediatrics|February 1, 2022
Pediatric Primary Health Care: The Central Role of Pediatricians in Maintaining Children's Health in Evolving Health Care ModelsAlexy Boudreau, Alex Hamling, Edward Pont, et al.
Alimentary Pharmacology & Therapeutics|September 10, 2016
Real-world effectiveness and safety of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin in hepatitis C: AMBER studyR Flisiak, E Janczewska, M Wawrzynowicz-Syczewska, et al.
Plos Neglected Tropical Diseases|November 20, 2019
Immune responses to O-specific polysaccharide (OSP) in North American adults infected with Vibrio cholerae O1 InabaMotaher Hossain, Kamrul Islam, Meagan Kelly, et al.
The New England Journal of Medicine|August 3, 2022
Trial of Cinpanemab in Early Parkinson's DiseaseAnthony E Lang, Andrew D Siderowf, Eric A Macklin, et al.
Journal of Parkinson'S Disease|April 5, 2024
Twelve Years of Drug Prioritization to Help Accelerate Disease Modification Trials in Parkinson's Disease: The International Linked Clinical Trials InitiativeRichard K Wyse, Tom Isaacs, Roger A Barker, et al.
Neurology|February 13, 2019
Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseasesAlberto J Espay, Joaquin A Vizcarra, Luca Marsili, et al.
Journal of Viral Hepatitis|January 10, 2018
Treatment of HCV infection in Poland at the beginning of the interferon-free era-the EpiTer-2 studyR Flisiak, D Zarębska-Michaluk, E Janczewska, et al.
AIDS Care|July 27, 2019
Real life results of direct acting antiviral therapy for HCV infection in HIV-HCV-coinfected patients: Epi-Ter2 studyA Piekarska, E Jabłonowska, A Garlicki, et al.
Annals of Neurology|March 28, 2012
Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2Nathan Pankratz, Gary W Beecham, Anita L DeStefano, et al.
Pageof 74

Showing results (711-720 of 732) with videos related to

Sort By:
Pageof 74
Neurology|January 20, 2010
Novel THAP1 sequence variants in primary dystoniaJ Xiao, Y Zhao, R W Bastian, et al.
Pediatrics|February 1, 2022
Pediatric Primary Health Care: The Central Role of Pediatricians in Maintaining Children's Health in Evolving Health Care ModelsAlexy Boudreau, Alex Hamling, Edward Pont, et al.
Alimentary Pharmacology & Therapeutics|September 10, 2016
Real-world effectiveness and safety of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin in hepatitis C: AMBER studyR Flisiak, E Janczewska, M Wawrzynowicz-Syczewska, et al.
Plos Neglected Tropical Diseases|November 20, 2019
Immune responses to O-specific polysaccharide (OSP) in North American adults infected with Vibrio cholerae O1 InabaMotaher Hossain, Kamrul Islam, Meagan Kelly, et al.
The New England Journal of Medicine|August 3, 2022
Trial of Cinpanemab in Early Parkinson's DiseaseAnthony E Lang, Andrew D Siderowf, Eric A Macklin, et al.
Journal of Parkinson'S Disease|April 5, 2024
Twelve Years of Drug Prioritization to Help Accelerate Disease Modification Trials in Parkinson's Disease: The International Linked Clinical Trials InitiativeRichard K Wyse, Tom Isaacs, Roger A Barker, et al.
Neurology|February 13, 2019
Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseasesAlberto J Espay, Joaquin A Vizcarra, Luca Marsili, et al.
Journal of Viral Hepatitis|January 10, 2018
Treatment of HCV infection in Poland at the beginning of the interferon-free era-the EpiTer-2 studyR Flisiak, D Zarębska-Michaluk, E Janczewska, et al.
AIDS Care|July 27, 2019
Real life results of direct acting antiviral therapy for HCV infection in HIV-HCV-coinfected patients: Epi-Ter2 studyA Piekarska, E Jabłonowska, A Garlicki, et al.
Annals of Neurology|March 28, 2012
Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2Nathan Pankratz, Gary W Beecham, Anita L DeStefano, et al.
Pageof 74